Colinz Laboratories P/B Ratio

Current P/B Ratio
0.65
Low Valuation
Low - Trading below book value, may indicate undervaluation

Colinz Laboratories (COLINZ) P/B ratio is 0.65 (Low), book value per share ₹33.33 vs Healthcare average P/B of -0.93 — Low - Trading below book value, may indicate undervaluation. Compare with Colinz Laboratories valuation methods to assess whether the stock is under or overvalued.

Current Valuation Metrics

P/B Ratio 0.65
Current Price ₹42.01
Book Value/Share ₹33.33
Exchange BSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹10 Cr
Share Capital ₹3 Cr
Reserves & Surplus ₹8 Cr
Outstanding Shares 3,000,000
Book Value per Share ₹33.33

Valuation Signal

Signal Undervalued
Historical Avg 1.77
Historical Range 1.26 - 2.33
Percentile 0.0%

Sector Context

Sector Average -0.93
Sector Median 0.6
Sector Rank #11 of 50
Sector Percentile 22.0%

COLINZ P/B Ratio — Valuation Insights & Book Value Analysis

Colinz Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 0.65 (Low). For live price, earnings yield and the full fundamental profile, see COLINZ screener.

  • Stock appears undervalued with PB of 0.65, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Current PB is 63.3% below historical average
  • Trading at premium to sector average PB of -0.93

Colinz Laboratories P/B Ratio Historical Trend

COLINZ annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View COLINZ 52-week high low for the annual high/low range and current price position.

COLINZ Historical P/B Ratio — Book Value Per Share & Year-End Price

Colinz Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 1.26 ₹33.33 ₹42.01 ₹10 Moderate
2025 1.61 ₹33.33 ₹53.63 ₹10 Moderate
2024 2.33 ₹30.0 ₹69.76 ₹9 Moderate
2023 1.5 ₹26.67 ₹40.00 ₹8 Moderate
2022 2.15 ₹20.0 ₹43.00 ₹8 Moderate

COLINZ vs Healthcare Peers — P/B Ratio Comparison

Colinz Laboratories P/B 0.65 vs Healthcare average -0.93, median 0.6 — range -31.21–1.04.

Sector Average
-0.93
Sector Median
0.6
Lowest P/B
-31.21
Highest P/B
1.04
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -31.21 ₹25 Low
Sun Pharma Advanced Rese… SPARC -16.05 ₹5,310 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.31 ₹75 Low
Parmax Pharma PARMAX -2.16 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.76 ₹121 Low
Cresanto Global CRESANTO -0.7 ₹2 Low